Literature DB >> 2440952

Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes.

S J Sargent, E H Beachey, C E Corbett, J B Dale.   

Abstract

Synthetic peptide fragments spanning the entire amino acid sequence of pep M5 were used to detect epitopes cross-reactive with heart tissue components other than myosin. Heart-cross-reactive pep M5 antibodies were affinity purified by absorption to and elution from purified sarcolemmal membranes. Only one of the synthetic peptides, SM5(164-197)C, inhibited reactivity of the affinity-purified antibodies with pep M5 by ELISA. SM5(164-197)C linked to KLH evoked both opsonic and heart-cross-reactive antibodies in rabbits. In addition to type 5, the immune sera opsonized M types 6, 18, 19, and 49 streptococci. The antisera reacted strongly with isolated cardiac sarcolemmal membranes by immunofluorescence. In Western blots of cardiac tissue, the anti-SM5(164-197)C reacted with a 40 kDa protein but not with myosin. The reaction was inhibited by pep M5 and SM5(164-197)C but not by any of the other peptides spanning pep M5. The cross-reactive anti-SM5(164-197)C affinity purified on sarcolemmal membranes opsonized types 5, 6, and 19 but not type 24 streptococci. These results indicate that SM5(164-197)C contains heart-cross-reactive, opsonic epitopes that are shared among heterologous serotypes of group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440952

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Authors:  E R Brandt; T Teh; W A Relf; R I Hobb; M F Good
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Molecular basis of virulence.

Authors:  T J Mitchell
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

4.  Phosphorylase-cross-reactive antibodies evoked by streptococcal M protein.

Authors:  J B Dale; H S Courtney; M Kotb; D Schifferli
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 5.  Molecular aspects of the phagocytosis resistance of group A streptococci.

Authors:  B N Manjula
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

Review 6.  Immunogenetic basis of myocarditis: role of fibrillary antigens.

Authors:  K W Beisel
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Mitral regurgitation may be related with previous streptococcal infection.

Authors:  M R Wahid; M Yoshinaga; Y Nomura; S Oku; S Takei; S Narahara
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 8.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

Review 9.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

10.  Fc-receptor and M-protein genes of group A streptococci are products of gene duplication.

Authors:  D G Heath; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.